Usted buscó: referenceintervallet (Danés - Inglés)

i kliniske studier blev der set et let fald i trombocyttallene, som forblev inden for referenceintervallet.
a slight decrease in platelet counts remaining within the normal range was observed in clinical studies.

i overensstemmelse med virkningen på akut fase reaktanter var behandlingen med tocilizumab ledsaget af et fald i trombocyttallet inden for referenceintervallet.
consistent with the effect on acute phase reactants, treatment with tocilizumab was associated with reduction in platelet count within the normal range.

i de kliniske studier blev der under behandlingen med mircera set et let fald i trombocyttallene, som var inden for referenceintervallet.
during treatment with mircera, a slight decrease in platelet counts remaining within the normal range was observed in clinical studies.

den daglige behandling med filgrastim bør fortsætte, indtil det forventede neutrofile nadir er passeret, og indtil neutrofiltallet er indenfor referenceintervallet.
daily dosing with filgrastim should continue until the expected neutrophil nadir is passed and the neutrophil count has recovered to the normal range.

under behandlingen med neorecormon kan der hos patienter med kronisk nyresvigt forekomme en moderat dosisafhængig stigning i trombocyttallet indenfor referenceintervallet, specielt efter intravenøs administration.
in chronic renal failure patients there may be a moderate dose-dependent rise in the platelet count within the normal range during treatment with neorecormon, especially after intravenous administration.

i de kliniske studier blev der under behandlingen med mircera set et let fald i trombocyttallene, som var inden for referenceintervallet trombocyttal under 100 x 109/l blev set hos 7% af de patienter, som blev behandlet med mircera og hos 4% af de patienter, som blev behandlet med esas.
during treatment with mircera, a slight decrease in platelet counts remaining within the normal range was observed in clinical studies.platelet counts below 100 x 109/l were observed in 7% of patients treated with mircera and 4% of patients treated with esas.